Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women

This publication has 30 references indexed in Scilit:

• Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Plasminogen activator inhibitors
  Blood, 1987
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
  Metabolism, 1986
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• Plasminogen activator inhibitor in the blood of patients with coronary artery disease.
  BMJ, 1985
• Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.
  BMJ, 1984
• Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.
  Circulation, 1983
• The Significance of Basal Insulin Levels in the Evaluation of the Insulin Response to Glucose in Diabetic and Nondiabetic Subjects*
  Journal of Clinical Investigation, 1967
• The Degree of Masculine Differentiation of Obesities
  The American Journal of Clinical Nutrition, 1956